![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_dc396853d8ecd1c829264434efab7a4c.svg) | 3-(4-Chloro-phenyl)-2-(4-methyl-2-methylamino-thiazol-5-yl)-3H-quinazolin-4-one | IC50 | 1200.0 [1], 3000.0 [2], 3300.0 [3] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_67f88e04314140ed512ee6234787c3ad.svg) | 2-[2-(4-Chloroanilino)-4-methyl-1,3-thiazol-5-yl]-3-(4-chlorophenyl)quinazolin-4-one | IC50 | 1200.0 [1], 3300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_2866865f97dc96f1ecbbbe21072e4b3b.svg) | 3-[5-(4-Cyclopentyloxy-2-hydroxybenzoyl)-2-[(3-oxo-1,2-benzoxazol-6-yl)methoxy]phenyl]propanoic acid | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_4f14be9fb906e6b8dfb1fac425bcd041.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_955314582bdcaf8fbeb95853c5b130c5.svg) | CID 10407641 | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_4d652f91b31ae655ffe4c86fc8565c92.svg) | CID 10499355 | IC50 | 4000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_49b18589429f38de0c9ff74cb6378551.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2,4-bis(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_a806a4175df78e2cab2ebbe8edd846fa.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-cyano-4-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_f9a19d5201bf01a1eabe0b39c7029860.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-6-chloro-4-(trifluoromethyl)pyridazine-3-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_afa925f4e591edc03b6bf7eb2e408900.svg) | CID 10666814 | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_5445e0f8f1c798883a1e75e5f8daaad7.svg) | N-(3,5-Bis-trifluoromethyl-phenyl)-4-chloro-2-trifluoromethyl-benzamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_7d1578d86c9fc15636b9e1a64e8bf66a.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-fluoro-4-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_0fe61f569116725cea897c2dc738c83d.svg) | CID 10741998 | IC50 | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_5ea987cd228c5b7589794304d19db7d9.svg) | CID 10763720 | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_4a0ecb54be056addc2ece54269cc27c7.svg) | 2-(4-Methyl-2-phenylamino-thiazol-5-yl)-3-o-tolyl-3H-quinazolin-4-one | IC50 | 5500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_7ab4277f9efa12bda9631ddd2cbcf539.svg) | 3-(4-Acetylphenyl)-2-(5-morpholin-4-yl-4-pyridin-4-ylthiophen-2-yl)quinazolin-4-one | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_6714455fbf4f44dfec468a4edd855b7b.svg) | Nagilactone F | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ee5dd42e8bfc5ff118b799670f4c6a57.svg) | 2-(4-Methyl-2-methylamino-thiazol-5-yl)-3-o-tolyl-3H-quinazolin-4-one | IC50 | 5500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_a44b6d39dd1c17e3c4db64141066f57b.svg) | Inumakilactone | IC50 | 4000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_0d8ee735fb9aaf2d3aa9673ccd5743a1.svg) | Rosmarinic acid | IC50 | 16200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ac539ec1473267b3ea601e275753ac34.svg) | (1E,4Z,6E)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one | IC50 | 12800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_b33d647a5a347bfb173a0ed912563556.svg) | (Z)-3-Amino-3-(4-aminophenylthio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile | IC50 | 2030.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_5192669b1e9fcb3eba808546c7480120.svg) | Cyqualon | IC50 | 7300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ef3bb5e9eebea0a564c792421c9ebf1b.svg) | 1-(5-Methoxy-2-(thiophen-2-yl)quinazolin-4-ylamino)-3-methyl-1H-pyrrole-2,5-dione | IC50 | 8.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_e6619a60592b21d760a88f55f09f0e79.svg) | Glaucarubinone | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_5228c4e5f225da64ea84ffac40134d90.svg) | Tylophorinidine | IC50 | 65.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_213baa97673ea822bd7ab2022be6bc80.svg) | Pergularinine | IC50 | 110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_f2d09a4bb9b2b4a2cb9d8a36fdba616a.svg) | Unii-txf835U41K | IC50 | 1067.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_04576e079ca29b1f5975a6a283d36adf.svg) | Momordine I | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_80df68eb0d00aa38eff6bd1d64179a5e.svg) | (1E,4E)-1,5-Di(pyridin-3-yl)penta-1,4-dien-3-one | IC50 | 4100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_4ef860f63fe5c230a291956012ddcfc1.svg) | 1,5-Bis(2-hydroxyphenyl)penta-1,4-dien-3-one | IC50 | 11700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_0c85deac4e07768928c53bb75b695060.svg) | Tylophoridicine E | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_cd61894ca48fc0fed76353b09f757973.svg) | 1-(6-Methoxy-2-thiophen-2-yl-quinazolin-4-ylamino)-3-methyl-pyrrole-2,5-dione | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_0edb58e8adebe5d75900544de9e8a5bb.svg) | 2-Anthracenecarboxylic acid, 9,10-dihydro-3,8-dihydroxy-9,10-dioxo-1-propyl- | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ad3f0ba9e4b898485a9044883084531d.svg) | [4-[(1E,4E)-5-(4-Acetyloxy-3-methoxyphenyl)-3-oxopenta-1,4-dienyl]-2-methoxyphenyl] acetate | IC50 | 8300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_7ff861b1d1708950749bc3d3391c08aa.svg) | 2-Phenyl-4-(2,5-dioxo-3-methyl-3-pyrroline-1-ylamino)pyrimidine-5-carboxylic acid ethyl ester | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_d3ced9c155539756ca1c160217727209.svg) | Ethyl 4-(3-methyl-2,5-dioxo-2H-pyrrol-1(5H)-ylamino)-2-(trifluoromethyl)pyrimidine-5-carboxylate | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_6235e3cad8f0ece1ac640d2481b1e0c1.svg) | Tylophorinicine | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_5d3f3e52d12e028a022fca0c549a4e96.svg) | [(1S,4S,5R,6R,7S,8R,11R,13S,17S,18S,19R)-4,5,17-Trihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-en-8-yl] 2-methylbutanoate | IC50 | 32.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_eb70554529ae6d82f597b7a44e84f55c.svg) | 2-(2-Thienyl)-4-(2,5-dioxo-3-methyl-3-pyrroline-1-ylamino)pyrimidine-5-carboxylic acid ethyl ester | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ec5199894a8b012a0f7dd21f758035f9.svg) | Ethyl 2-[(3-methyl-2,5-dioxopyrrol-1-yl)amino]-4-(5-methylthiophen-2-yl)pyrimidine-5-carboxylate | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_284686b0b610d5a0d9e6178c90c116d1.svg) | Ethyl 4-ethyl-2-[methyl-(3-methyl-2,5-dioxopyrrol-1-yl)amino]pyrimidine-5-carboxylate | IC50 | 35.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_4952bfa9a1f7a3f9ecc823d1c9b25cb2.svg) | (1E,4E)-1,5-Bis(2,5-dimethoxyphenyl)penta-1,4-dien-3-one | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_a07b551c2782dde2727c470275883014.svg) | 3-[2-Isobutoxy-5-(4-isobutoxybenzoyl)phenyl]propionic acid | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_0a3d2915920d3c142312dcae75d53dfb.svg) | Ethyl 4-ethyl-2-[(3-methyl-2,5-dioxopyrrol-1-yl)amino]pyrimidine-5-carboxylate | IC50 | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_95f6d687b16af60e6758d6a502650ea7.svg) | Ethyl 2-[methyl-(3-methyl-2,5-dioxopyrrol-1-yl)amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_a652070340c5dfef02b6da66f42e5606.svg) | 1-[[5-Benzoyl-4-(trifluoromethyl)pyrimidin-2-yl]amino]-3-methylpyrrole-2,5-dione | IC50 | 98.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_474841a0e8e73ce03fd3c2790c366c6c.svg) | Ethyl 2-[(3-methyl-2,5-dioxopyrrol-1-yl)amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_f2774d69f8485b77ee559ec4f00aec66.svg) | Tert-butyl 2-[(3-methyl-2,5-dioxopyrrol-1-yl)amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate | IC50 | 210.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ca33572482a1a186d0d8f9e44a75ef13.svg) | 1-[[5-Acetyl-4-(trifluoromethyl)pyrimidin-2-yl]amino]-3-methylpyrrole-2,5-dione | IC50 | 4400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_b35015329e5fb75d302403e580e3b0ae.svg) | 7-(1-Methylpyrazol-4-yl)-N-[4-(3-morpholin-4-yl-1,2,4-triazol-1-yl)phenyl]quinazolin-2-amine | IC50 | 310.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_f6045fa6e57c7d489d96f1f70123cd4f.svg) | Grassypeptolide F | IC50 | 5200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_4f490fe14af8f3f6ebcc971720880159.svg) | Grassypeptolide G | IC50 | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_701dcf05b69d97aed6166c719a3ce80e.svg) | 2-Chloro-8-(trifluoromethyl)-6H-pyrimido[4,5-b][1,5]benzothiazepin-5-one | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_011318b1b87499aa0efa5d512a98e716.svg) | (Z)-3-[(1S,2S,4S,5S,6S,7S)-5-Hydroxy-10-methoxycarbonyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,8-dioxatricyclo[4.4.0.02,4]dec-9-ene-5-carbonyl]oxy-2-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid | IC50 | 29000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_31e62f79df7780c942c63cf811237e34.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_cb5b216a188a3e1d2a5245cbd258787e.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_3aabc5e5851319b1bef9ce7fa92b3300.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-(1,1,2,2,2-pentafluoroethyl)pyrimidine-5-carboxamide | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_c86a1ff9622e7bfb0023be1c809e3007.svg) | CID 10666813 | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_0fbb795d7aee17f32e51bb86dd6e0d24.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2,6-dichloropyrimidine-4-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_13feb511c7d846c9caa39be233ca2d3e.svg) | CID 10716536 | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_03a10b1c56b515b6917ca40ebb11d747.svg) | CID 10716588 | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_2a6216b62939379eaa72044ea01f3398.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-6-(trifluoromethyl)pyrimidine-4-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_67721cfc3fd61f7df446540c3335ad2d.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-methyl-4-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_e492fffdeb1233bd61bb06f68ccfe1c4.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-6-methylpyrimidine-4-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_9519f6c296a62e4e08d9c1fe009e661d.svg) | CID 10787015 | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_b70b4e50bfedd98fa90020193c0fff5a.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-2-(trifluoromethyl)pyrimidine-5-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_c305ca2b008c3b18eb7e6823d75b9db3.svg) | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-thiophen-2-ylpyrimidine-5-carboxamide | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_e2e43298568cc8e821d5209c345e7f51.svg) | N-Ethyl-4-[[4-(1H-indol-3-yl)-5-methylpyrimidin-2-yl]amino]piperidine-1-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_591e0762752e60680bdbc815430cc2cd.svg) | N-[2-[4-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidin-1-yl]-2-oxoethyl]acetamide | IC50 | 1938.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ee49924c23a1b21f4f01e45a63af0ee1.svg) | 2-Chloro-N-(3,5-dichlorophenyl)-4-methylpyrimidine-5-carboxamide | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_eb668be6aebeb24e38902bb1e2fa1b5e.svg) | N-[2,4-Bis(trifluoromethyl)phenyl]-2-chloro-6-(trifluoromethyl)pyrimidine-4-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_fa8c17511faa31ef0b217988d5936e96.svg) | N-[2,4-Bis(trifluoromethyl)phenyl]-2-chloro-6-methylpyrimidine-4-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_2a2e311a4177025d3b0997cb21e7f2c2.svg) | [2-Chloro-4-(trifluoromethyl)pyrimidin-5-yl]-[7-(trifluoromethyl)-2,4-dihydro-3,1-benzoxazin-1-yl]methanone | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_7c7f7e9fbb78ef7ce57b4341c773819f.svg) | 6-[3,5-Bis(trifluoromethyl)phenyl]-2-chloropyrrolo[3,4-d]pyrimidine-5,7-dione | IC50 | 9400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_aa0e6db2c801081445f4de73b9cd3677.svg) | 6-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-chloropyrrolo[3,4-d]pyrimidine-5,7-dione | IC50 | 9400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_8de683feaf60fc877025a9c3d684fd40.svg) | 2-Chloro-8-(trifluoromethyl)-6H-pyrimido[5,4-c]quinolin-5-one | IC50 | 6100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_56b00c7d1e861d73d118dbc7bea10d35.svg) | 2-Chloro-8-(trifluoromethyl)-6,11-dihydropyrimido[5,4-c][1]benzazepin-5-one | IC50 | 8500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_34bfeaa8d8a633821efdb719e9411dfe.svg) | 2-Chloro-8-(trifluoromethyl)-6,11-dihydropyrimido[5,4-c][1,5]benzodiazepin-5-one | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_50254c8b99a0200a0e4bf0519c1d242d.svg) | 2-Chloro-8-(trifluoromethyl)-6H-pyrimido[4,5-b][1,5]benzoxazepin-5-one | IC50 | 1900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_707c491d98aab34dfe49c0bb46bc7007.svg) | 1-[[4-Ethyl-5-(2-methyl-1,3-oxazol-4-yl)pyrimidin-2-yl]amino]-3-methylpyrrole-2,5-dione | IC50 | 830.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_2ae9734f3291fd341428dc1f167d4063.svg) | 3-Methyl-1-[[5-(2-methyl-1,3-oxazol-4-yl)-4-thiophen-2-ylpyrimidin-2-yl]amino]pyrrole-2,5-dione | IC50 | 760.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_642a5e9ed94064f4592e05b85b9bf048.svg) | (Z)-3-[(1S,4As,7S,7aS)-7-hydroxy-4-methoxycarbonyl-5-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1H-cyclopenta[c]pyran-7-carbonyl]oxy-2-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid | IC50 | 69600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_e7c1adf2c61c7a73e2a5dfaf34490f73.svg) | (1E,4E)-1,5-Di(pyridin-4-yl)penta-1,4-dien-3-one | IC50 | 8200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_f5c6789a10bbfcddc6f13490d6776939.svg) | (1E,4Z,6E)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-4-methylhepta-1,4,6-trien-3-one | IC50 | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_75c4dd74144792ffbd3b8df9f6c56dc2.svg) | 4-{[5-Chloro-4-(1h-Indol-3-Yl)pyrimidin-2-Yl]amino}-N-Ethylpiperidine-1-Carboxamide | IC50 | 704.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_d9cd692b6197a543504ef6ea7df2419c.svg) | Ethyl N-[5-[3-(4-chlorophenyl)-4-oxoquinazolin-2-yl]-4-methyl-1,3-thiazol-2-yl]carbamate | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_ef345143b2545c0f0e0123c59d49df12.svg) | 3-(2-Methoxyphenyl)-2-[2-(methylamino)-4-phenyl-1,3-thiazol-5-yl]quinazolin-4-one | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_01de0ce8c1fecb39d48deaaa7651e625.svg) | 4-[[5-Cyano-4-(6-fluoro-1H-indol-3-yl)pyrimidin-2-yl]amino]-N-ethylpiperidine-1-carboxamide | IC50 | 3700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_6814cad5b2d5af334197d58fe248c1ab.svg) | 4-(4-(1H-Indol-3-yl)pyrimidin-2-ylamino)-N-ethylpiperidine-1-carboxamide | IC50 | 8091.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_8e153b97cc6dd2a8359358a00c3503ad.svg) | 4-[(5-Chloro-4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]-N-ethylpiperidine-1-carboxamide | IC50 | 7723.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_9bbc55e8b847c3eec9b9684508028540.svg) | 4-[(5-Chloro-4-indol-1-ylpyrimidin-2-yl)amino]-N-ethylpiperidine-1-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_fccc9c7ebda2e2d888a3337ea7952587.svg) | N-Ethyl-4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidine-1-carboxamide | IC50 | 19331.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_25111ad01240543139f3d7ddd02ca93e.svg) | 4-(4-(1H-Indol-1-yl)pyrimidin-2-ylamino)-N-ethylpiperidine-1-carboxamide | IC50 | 29891.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_da50e11f5c17588edb9c2e8e7058e922.svg) | 3-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-N-ethylpyrrolidine-1-carboxamide | IC50 | 6268.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_2b33a5470f2d0ab0055a9c2fa7ba7a29.svg) | 3-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-N-ethylazetidine-1-carboxamide | IC50 | 4272.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_c8f8e765ab6f6cad4bedacb8a8e392fa.svg) | (3S)-3-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-N-ethylpiperidine-1-carboxamide | IC50 | 6995.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_047af168bafcd9106d45b7e9c6e92c43.svg) | 2-[(3S)-3-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidin-1-yl]-N-methylacetamide | IC50 | 14667.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_5983a9a8f9f58fa786baa1104a9a9992.svg) | (3R)-3-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-N-ethylpiperidine-1-carboxamide | IC50 | 3883.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-c-jun_01d00eb858b88d31a6be126b9a253c03.svg) | 2-[(3R)-3-[[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidin-1-yl]-N-methylacetamide | IC50 | 2807.0 [1] |